Dharani Sai Sreekanth Nellore

Dharani Sai Sreekanth Nellore

Auto-generated profile, based on publicly available information

Dharani Sai Sreekanth Nellore

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Králové Charles University Hradec Kralove Czech Republic

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2026 in Angewandte Chemie
Verified
Journal Article
Open access
Rajamanikkam KamarajRajamanikkam Kamaraj
Rajamanikkam Kamaraj
ARAzam Rashidian
Azam Rashidian
DNDharani Sai Sreekanth Nellore
Dharani Sai Sreekanth Nellore
LMLevi Miederer
Levi Miederer
IMIvana Mejdr
Ivana Mejdr
PPPetr Pavek
Petr Pavek
The pregnane X receptor (PXR) displays exceptional ligand promiscuity, yet the molecular basis of its antagonism remains poorly defined. PXR inhibition has traditionally been attributed to the displacement of coactivators from the activation function‐2 (AF‐2) surface. Here, we show that PXR antagonism is mechanistically heterogeneous, with distinct inhibitory mechanisms determined by ligand structure. Comparative analysis of imidazo[1,2‐a]pyridine, MI891, and SPA70 antagonists reveals multiple non‐canonical inhibitory mechanisms that decouple coregulator recruitment from transcriptional output. Notably, SPA70 preserves compatibility with coactivator recruitment while remaining transcriptionally inactive, consistent with concurrent corepressor engagement and a distinct coactivator‐compatible antagonist state. In contrast, MI891 stabilizes a PXR conformation that favors NCoR1 and SMRT binding and impairs nuclear translocation. MD simulations and mutagenesis reveal ligand‐specific perturbations of α12 and the α10/α11 region that underlie these effects. Together, these findings establish a ligand‐encoded framework for PXR antagonism that extends beyond the classical on/off switch model.

8 November 2026 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
Rajamanikkam KamarajRajamanikkam Kamaraj
Rajamanikkam Kamaraj
ARAzam Rashidian
Azam Rashidian
DNDharani Sai Sreekanth Nellore
Dharani Sai Sreekanth Nellore
LMLevi Miederer
Levi Miederer
IMIvana Mejdr
Ivana Mejdr
PPPetr Pavek
Petr Pavek
The pregnane X receptor (PXR) displays exceptional ligand promiscuity, yet the molecular basis of its antagonism remains poorly defined. PXR inhibition has traditionally been attributed to the displacement of coactivators from the activation function‐2 (AF‐2) surface. Here, we show that PXR antagonism is mechanistically heterogeneous, with distinct inhibitory mechanisms determined by ligand structure. Comparative analysis of imidazo[1,2‐a]pyridine, MI891, and SPA70 antagonists reveals multiple non‐canonical inhibitory mechanisms that decouple coregulator recruitment from transcriptional output. Notably, SPA70 preserves compatibility with coactivator recruitment while remaining transcriptionally inactive, consistent with concurrent corepressor engagement and a distinct coactivator‐compatible antagonist state. In contrast, MI891 stabilizes a PXR conformation that favors NCoR1 and SMRT binding and impairs nuclear translocation. MD simulations and mutagenesis reveal ligand‐specific perturbations of α12 and the α10/α11 region that underlie these effects. Together, these findings establish a ligand‐encoded framework for PXR antagonism that extends beyond the classical on/off switch model.